Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2016 participants
OBSERVATIONAL
2020-08-04
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Low-voltage Areas Defragmentation in Sinus Rhythm for Radiofrequency Ablation of Persistent Atrial Fibrillation
NCT04045067
AcQBlate Force Sensing Ablation System US IDE for Atrial Flutter (AcQForce Flutter)
NCT04658940
Investigation of the Adagio Cryoablation System in Patients With Atrial Fibrillation
NCT02839304
Cryoballoon Atrial Fibrillation Ablation Registry
NCT03040037
Atherosclerosis in Atrial Fibrillation
NCT01882114
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patient Registry Data
To set data on demographic characteristics,documenting antithrombotic therapy, describe the INR control level of VKA users, discontinuation rates and clinical outcomes, such as stroke, hemorrhage and death.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Atrial Fibrillation or Atrial Flutter at the time of inclusion documented in source document;
* If the patient is not in atrial fibrillation or Atrial Flutter rhythm, s/he should have 2 electrographic records, at least 15 days apart between them, with one of them being performed within the last 6 months before enrollment (AF may be documented by 12-lead ECG, Holter monitor-24h);
Exclusion Criteria
* Patients without possibility of monitoring for one year.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Brazilian Clinical Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Renato D. Lopes, MD, PhD
Role: STUDY_CHAIR
Instituto Brasileiro de Pesquisa Thomaz de Carvalho - BCRI
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Interzonal General de Agudos "Dr. José Penna"
Bahía Blanca, Buenos Aires, Argentina
DIM Clínica Privada
Ramos Mejía, Buenos Aires, Argentina
Centro de Investigaciones Medicas Temperley (CIMeT)
Temperley, Buenos Aires, Argentina
Hospital Italiano de La Plata
Buenos Aires, La Plata, Argentina
Centro Modelo de Cardiologia
San Miguel de Tucumán, Tucumán Province, Argentina
Centro Medico Luquez
Córdoba, , Argentina
Prevención Cardiovascular Salta
Salta, , Argentina
Servicios Médicos El Castaño
San Juan, , Argentina
Instituto Cardiovascular San Luis
San Luis, , Argentina
Centro de Investigaciones Clinicas del Litoral SRL
Santa Fe, , Argentina
Hospital Provincial Dr. José Maria Cullen
Santa Fe, , Argentina
Hospital Alvorada Taguatinga Ltda
São Paulo, , Brazil
Sociedad de Cirugia de Bogota - Hospital de San Jose
Bogotá, Cundinamarca, Colombia
Fundacion Valle del Lili
Cali, Valle del Cauca Department, Colombia
Francisco Gerardo Padilla Padilla
Guadalajara, Jalisco, Mexico
Centro de Estudios Clínicos de Queretaro S.C. (CECLIQ)
Querétaro City, Querétaro, Mexico
Centro para el Desarrollo de la Medicina y de Asistecia Medica Especializada S.C.
Culiacán, Sinaloa, Mexico
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
001/2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.